WHO ICTRP trial
Single and Multiple Dose Study of MK-0616 in Healthy Japanese Participants
JPRN-jRCT2031210233 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-jRCT2031210233 |
|---|---|
| Public title | Single and Multiple Dose Study of MK-0616 in Healthy Japanese Participants |
| Scientific title | A Single- and Multiple-Dose Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics of MK-0616 in Healthy Japanese Participants. |
| Primary sponsor | Tanaka Yoshiyuki |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | 1 |
| Conditions | Hypercholesterolemia |
| Interventions | -Palens A, B and C Single dose of MK-0616 5, 10, 20, 40, 100 or 200 mg, or matching placebo will be administerd in Periods 1 and 2, respectively. -Panel D Multiple doses of MK-0616 30 mg, or matching placebo will be administered once daily… |
| Registration date | Jun 8, 2021 |
| Target size | 48 |
| Secondary IDs | Nil known |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: